← Eichor
Study identifier: NCT07262372 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Supervision in Substance Use Disorder Treatment Programs

Condition: Self Efficacy · Burnout, Professional · Substance Use Disorders  ·  Sponsor: University of Arkansas

PhaseNA
Planned participants43
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Substance use disorders such as opioid addiction affect millions of adults in the United States each year, but the delivery of high-quality, effective addiction services is disrupted by organizational issues such as counselor burnout and turnover. Clinical supervisors are essential for supporting counselors in specialty addiction treatment programs, but few supervisors receive supervision-focused training. This project seeks to develop and pilot an evidence-based supervision strategy that has a high potential to enhance supervision and result in improved counselors' well-being and performance and, in turn, to improve client outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Jure Baloh, PhD  ·  501 526 6604  ·  jbaloh@uams.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Arkansas for Medical SciencesLittle Rock, Arkansas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07262372